Results 111 to 120 of about 12,641,387 (374)
2-closures of primitive permutation groups of holomorph type
Open Mathematics, 2019 The 2-closure G(2) of a permutation group G on a finite set Ω is the largest subgroup of Sym(Ω) which has the same orbits as G in the induced action on Ω × Ω.
Yu Xue, Pan Jiangmin
doaj +1 more source
A Novel Algorithm of Constructing Highly Nonlinear S-p-boxes
Cryptography, 2019 The role of substitution boxes is very important in block ciphers. Substitution boxes are utilized to create confusion in the cryptosystem. However, to create both confusion and diffusion in any cryptosystem p-boxes and chaos base substitution boxes are ...
Yasir Naseer +3 more
doaj +1 more source
A Remark on Decompositions of the Permutation Representation of a Permutation Group [PDF]
Nagoya Mathematical Journal, 1963 Let be a permutation group on n-letters 1, 2,… ,n . Let be the subgroup of fixing suitable one letter, say 1.
openaire +3 more sources
Molecular Oncology, EarlyView.Urine is a rich source of biomarkers for cancer detection. Tumor‐derived material is released into the bloodstream and transported to the urine. Urine can easily be collected from individuals, allowing non‐invasive cancer detection. This review discusses the rationale behind urine‐based cancer detection and its potential for cancer diagnostics ...
Birgit M. M. Wever +1 more
wiley +1 more source
Molecular Oncology, EarlyView.Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker +14 more
wiley +1 more source
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Molecular Oncology, EarlyView.Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source
Molecular Oncology, EarlyView.The authors applied joint/mixed models that predict mortality of trifluridine/tipiracil‐treated metastatic colorectal cancer patients based on circulating tumor DNA (ctDNA) trajectories. Patients at high risk of death could be spared aggressive therapy with the prospect of a higher quality of life in their remaining lifetime, whereas patients with a ...
Matthias Unseld +7 more
wiley +1 more source
Representing the Quotient Groups of a Finite Permutation Group
, 2002 Let G be a permutation group of finite degree d. We prove that the product of the orders of the composition factors of G that are not alternating groups acting naturally, in a sense that will be made precise, is bounded by cd − 1/d, where c = 4.5. We use
D. Holt, J. Walton
semanticscholar +1 more source
The Valence-Bond (VB) Model and Its Intimate Relationship to the Symmetric or Permutation Group. [PDF]
Molecules, 2021 Nascimento MAC.
europepmc +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
Molecular Oncology, EarlyView.mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia +17 more
wiley +1 more source